Hannu Maaheimo

Hannu Maaheimo

Auto-generated profile, based on publicly available information

Hannu Maaheimo

VTT Technical Research Centre PO Box 1000 Espoo FI‐02044 Finland

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MJMikael Johansson
Mikael Johansson
HMHannu Maaheimo
Hannu Maaheimo
FEFilip Ekholm
Filip Ekholm
Antibody-drug conjugates (ADCs) are emerging as a promising class of selective drug delivery systems in the battle against cancer and other diseases. The auristatins monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF) appear as the cytotoxic drug in almost half of the state-of-the-art ADCs on the market or in late stage clinical trials. Here, we present the first complete NMR spectroscopic characterisation of these challenging molecules, and investigate their structural properties by a combined NMR and quantum chemical modelling approach. We find that in solution, half of the drug molecules are locked in an inactive conformation, severely decreasing their efficiency, and potentially increasing the risk of side-effects. Furthermore, we identify sites susceptible to future modification, in order to potentially improve the performance of these drugs.

18 October 2004 in Planta Medica
Verified
Journal Article
Closed access
PDF file
Suvi T. HäkkinenSuvi T. Häkkinen
Suvi T. Häkkinen
Heiko RischerHeiko Rischer
Heiko Rischer
ILInto Laakso
Into Laakso
HMHannu Maaheimo
Hannu Maaheimo
TSTuulikki Seppanen-Laakso
Tuulikki Seppanen-Laakso
Kirsi Marja OksmanKirsi Marja Oksman
Kirsi Marja Oksman
Anatalline [2,4-di(3-pyridyl)piperidine] accumulation was shown to be induced by methyl jasmonate in Nicotiana tabacum cv. BY-2 cell cultures. Beside anatabine, anatalline represented the most abundant alkaloid, moreover, it was always present in two isomeric forms occurring always in similar concentrations. Both isomers could be completely separated by GC-MS. For structural analysis, the isolation of both isomers was performed using a semi-preparative HPLC system. The structures of anatalline [cis-2,4-di(3-pyridyl)piperidine] and its stereoisomer trans-2,4-di(3-pyridyl)piperidine were confirmed by MS and 1D and 2D NMR spectral data. The biosynthetic origin of anatalline was studied by feeding alkaloid precursors to BY-2 cell cultures.

27 February 2006 in Bioinformatics
Verified
Journal Article
Open access
PDF file
ARAri Rantanen
Ari Rantanen
TMTaneli Mielikäinen
Taneli Mielikäinen
JRJuho Rousu
Juho Rousu
HMHannu Maaheimo
Hannu Maaheimo
EUEsko Ukkonen
Esko Ukkonen
Motivation: Flux estimation using isotopomer information of metabolites is currently the most reliable method to obtain quantitative estimates of the activity of metabolic pathways. However, the development of isotopomer measurement techniques for intermediate metabolites is a demanding task. Careful planning of isotopomer measurements is thus needed to maximize the available flux information while minimizing the experimental effort. Results: In this paper we study the question of finding the smallest subset of metabolites to measure that ensure the same level of isotopomer information as the measurement of every metabolite in the metabolic network. We study the computational complexity of this optimization problem in the case of the so-called positional enrichment data, give methods for obtaining exact and fast approximate solutions, and evaluate empirically the efficacy of the proposed methods by analyzing a metabolic network that models the central carbon metabolism of Saccharomyces cerevisiae. Contact:ajrantan@cs.helsinki.fi

11 April 1995 in Biochemistry
Verified
Journal Article
Closed access
ASAntti Seppo
Antti Seppo
LPLeena Penttila
Leena Penttila
RNRitva Niemela
Ritva Niemela
HMHannu Maaheimo
Hannu Maaheimo
OROssi Renkonen
Ossi Renkonen
AKAnita Keane
Anita Keane

8 December 2009 in Magnetic Resonance in Chemistry
Verified
Journal Article
Closed access
PDF file
MTMika Tiainen
Mika Tiainen
HMHannu Maaheimo
Hannu Maaheimo
PSPasi Soininen
Pasi Soininen
RLReino Laatikainen
Reino Laatikainen

2 December 2019 in Glycoconjugate Journal
Verified
Journal Article
Open access
PDF file
AUAnne Usvalampi
Anne Usvalampi
MMMarcela Ruvalcaba Medrano
Marcela Ruvalcaba Medrano
HMHannu Maaheimo
Hannu Maaheimo
HSHeidi Salminen
Heidi Salminen
OTOlli Tossavainen
Olli Tossavainen
AFAlexander D. Frey
Alexander D. Frey
Fucosylated oligosaccharides are interesting molecules due to their bioactive properties. In particular, their application as active ingredient in milk powders is attractive for dairy industries. The objective of this study was to characterize the glycosyl hydrolase family 29 α-fucosidase produced byAspergillus nigerand test its ability to transfucosylate lactose with a view towards potential industrial applications such as the valorization of the lactose side stream produced by dairy industry. In order to reduce costs and toxicity the use of free fucose instead of environmentally questionable fucose derivatives was studied. In contrast to earlier studies, a recombinantly producedA. nigerα-fucosidase was utilized. Using pNP-fucose as substrate, the optimal pH for hydrolytic activity was determined to be 3.8. The optimal temperature for a 30-min reaction was 60 °C, and considering temperature stability, the optimal temperature for a 24-h reaction was defined as 45 °C For the same hydrolysis reaction, the kinetic values were calculated to be 0.385 mM for the KMand 2.8 mmol/(mg*h) for the Vmax. Transfucosylation of lactose occurred at high substrate concentrations when reaction time was elongated to several days. The structure of the product trisaccharide was defined as 1-fucosyllactose, where fucose is α-linked to the anomeric carbon of the β-glucose moiety of lactose. Furthermore, the enzyme was able to hydrolyze its own transfucosylation product and 2′-fucosyllactose but only poorly 3-fucosyllactose. As a conclusion, α-fucosidase fromA. nigercan transfucosylate lactose using free fucose as substrate producing a novel non-reducing 1-fucosyllactose.